D. Parkin, F. Bray, and S. Devesa, Cancer burden in the year 2000. The global picture, European Journal of Cancer, vol.37, p.66, 2001.
DOI : 10.1016/S0959-8049(01)00267-2

B. Feldman and D. Feldman, The development of androgen-independent prostate cancer, Nature Reviews Cancer, vol.1, issue.1, pp.34-45, 2001.
DOI : 10.1038/35094009

W. Isaacs and T. Kainu, Oncogenes and Tumor Suppressor Genes in Prostate Cancer, Epidemiologic Reviews, vol.23, issue.1, pp.36-41, 2001.
DOI : 10.1093/oxfordjournals.epirev.a000794

E. Ostrander, K. Markianos, and J. Stanford, FINDING PROSTATE CANCER SUSCEPTIBILITY GENES, Annual Review of Genomics and Human Genetics, vol.5, issue.1, pp.151-75, 2004.
DOI : 10.1146/annurev.genom.5.061903.180044

K. Porkka and T. Visakorpi, Molecular Mechanisms of Prostate Cancer, European Urology, vol.45, issue.6, pp.683-91, 2004.
DOI : 10.1016/j.eururo.2004.01.012

K. Landers, M. Burger, M. Tebay, D. Purdie, B. Scells et al., Use of multiple biomarkers for a molecular diagnosis of prostate cancer, International Journal of Cancer, vol.18, issue.3, pp.950-956, 2005.
DOI : 10.1002/ijc.20760

G. Fromont, L. Chene, M. Vidaud, G. Vallancien, P. Mangin et al., Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR, International Journal of Cancer, vol.94, issue.2, pp.174-81, 2005.
DOI : 10.1002/ijc.20704

S. Tomlins, D. Rhodes, S. Perner, S. Dhanasekaran, R. Mehra et al., Chinnaiyan AM: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, issue.5748, pp.310644-310652, 2005.

W. Ellis, R. Vessella, K. Buhler, F. Bladou, L. True et al., Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23, Clin Cancer Res, vol.2, issue.6, pp.1039-1087, 1996.

S. Mousses, U. Wagner, Y. Chen, J. Kim, L. Bubendorf et al., Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling, Oncogene, vol.20, issue.46, pp.206718-206741, 2001.
DOI : 10.1038/sj.onc.1204889

W. Van-weerden and J. Romijn, Use of nude mouse xenograft models in prostate cancer research, The Prostate, vol.20, issue.4, pp.263-271, 2000.
DOI : 10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I

J. Kononen, L. Budendorf, A. Kallioniemi, M. Barlund, P. Schraml et al., Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nature Medicine, vol.54, issue.7, pp.844-847, 1998.
DOI : 10.1023/A:1005769925670

C. Theillet, A. J. Louason, G. Bonnet-dorion, F. Jacquemier, J. Adane et al., FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers, Genes, Chromosomes and Cancer, vol.4, issue.4, pp.219-226, 1993.
DOI : 10.1002/gcc.2870070407

F. Bertucci, V. Nasser, S. Granjeaud, F. Eisinger, A. J. Tagett et al., Gene expression profiles of poor-prognosis primary breast cancer correlate with survival, Human Molecular Genetics, vol.11, issue.8, pp.11863-72, 2002.
DOI : 10.1093/hmg/11.8.863

E. Devilard, F. Bertucci, P. Trempat, R. Bouabdallah, B. Loriod et al., Gene expression profiling defines molecular subtypes of classical Hodgkin's disease, Oncogene, vol.21, issue.19, pp.3095-3102, 2002.
DOI : 10.1038/sj.onc.1205418

M. Eisen, P. Spellman, P. Brown, and D. Botstein, Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.24, issue.2, pp.9514863-14868, 1998.
DOI : 10.1016/0092-8674(81)90326-3

J. Richter, U. Wagner, J. Kononen, A. Fijan, J. Bruderer et al., High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer, The American Journal of Pathology, vol.157, issue.3, pp.787-794, 2000.
DOI : 10.1016/S0002-9440(10)64592-0

F. Bertucci, S. Van-hulst, K. Bernard, B. Loriod, S. Granjeaud et al., Expression scanning of an array of growth control genes in human tumor cell lines, Oncogene, vol.18, issue.26, pp.183905-3912, 1999.
DOI : 10.1038/sj.onc.1202731

J. Edwards, N. Krishna, C. Witton, and J. Bartlett, Gene amplifications associated with the development of hormone-resistant prostate cancer, Clin Cancer Res, vol.9, issue.14, pp.5271-81, 2003.

J. Jacquemier, C. Ginestier, J. Rougemont, V. Bardou, E. Charafe-jauffret et al., Protein expression profiling identifies subclasses of breast cancer and predicts prognosis, Cancer Res, issue.3, pp.65767-79, 2005.

S. Varambally, J. Yu, B. Laxman, D. Rhodes, R. Mehra et al., Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression, Cancer Cell, vol.8, issue.5, pp.393-406, 2005.
DOI : 10.1016/j.ccr.2005.10.001

L. Amler, D. Agus, C. Leduc, M. Sapinoso, W. Fox et al., Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1, Cancer Res, issue.21, pp.606134-606138, 2000.

S. Mousses, L. Bubendorf, U. Wagner, G. Hostetter, J. Kononen et al., Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays, Cancer Res, issue.5, pp.621256-60, 2002.

S. Feng, F. Wang, A. Matsubara, M. Kan, and W. Mckeehan, Fibroblast growth factor receptor 2 limits and receptor 1 acceleratestumorigenicity of prostate epithelial cells, Cancer Res, vol.57, issue.23, pp.5369-78, 1997.

K. Gravdal, O. Halvorsen, S. Haukaas, and L. Akslen, Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer, Virchows Archiv, vol.12, issue.2, pp.68-74, 2005.
DOI : 10.1007/s00428-005-0075-3

K. Busam, Y. Chen, L. Old, E. Stockert, K. Iversen et al., Expression of Melan-A (MART1) in Benign Melanocytic Nevi and Primary Cutaneous Malignant Melanoma, The American Journal of Surgical Pathology, vol.22, issue.8, pp.22976-82, 1998.
DOI : 10.1097/00000478-199808000-00007

S. Yan and J. Brennick, False-positive Rate of the Immunoperoxidase Stains for MART1/MelanA in Lymph Nodes, The American Journal of Surgical Pathology, vol.28, issue.5, pp.596-600, 2004.
DOI : 10.1097/00000478-200405000-00005

L. Rivoltini, P. Squarcina, D. Loftus, C. Castelli, P. Tarsini et al., A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy, Cancer Res, vol.59, issue.2, pp.301-307, 1999.

F. Gergely, D. Kidd, K. Jeffers, J. Wakefield, and J. Raff, D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo, The EMBO Journal, vol.20, issue.2, pp.241-52, 2000.
DOI : 10.1093/emboj/19.2.241

I. Still, M. Hamilton, P. Vince, A. Wolfman, and J. Cowell, Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon, Oncogene, vol.18, issue.27, pp.4032-4040, 1999.
DOI : 10.1038/sj.onc.1202801

I. Still, P. Vince, and J. Cowell, The Third Member of the Transforming Acidic Coiled Coil-Containing Gene Family, TACC3, Maps in 4p16, Close to Translocation Breakpoints in Multiple Myeloma, and Is Upregulated in Various Cancer Cell Lines, Genomics, vol.58, issue.2, pp.165-70, 1999.
DOI : 10.1006/geno.1999.5829

H. Chen, K. Schmeichel, I. Mian, S. Lelievre, O. Petersen et al., AZU-1: A Candidate Breast Tumor Suppressor and Biomarker for Tumor Progression, Molecular Biology of the Cell, vol.11, issue.4, pp.1357-67, 2000.
DOI : 10.1091/mbc.11.4.1357

F. Ugolini, A. J. Charafe-jauffret, E. Nguyen, C. Jacquemier, J. Jordan et al., Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes, Oncogene, vol.18, issue.10, pp.181903-181913, 1999.
DOI : 10.1038/sj.onc.1202739

N. Conte, E. Charafe-jauffret, B. Delaval, A. J. Ginestier, C. Geneix et al., Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators, Oncogene, vol.21, issue.36, pp.5619-5649, 2002.
DOI : 10.1038/sj.onc.1205658

Z. Wang, Q. Qiu, K. Enger, and T. Deuel, A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1., Proceedings of the National Academy of Sciences, vol.90, issue.19, pp.908896-900, 1993.
DOI : 10.1073/pnas.90.19.8896

H. Werner, C. Roberts, . Jr, F. Rauscher, and D. Leroith, Regulation of insulin-like growth factor I receptor gene expression by the wilms??? tumor supressor WT1, Journal of Molecular Neuroscience, vol.169, issue.2, pp.111-134, 1996.
DOI : 10.1007/BF02736791

R. Shimamura, G. Fraizer, J. Trapman, L. Yfc, and G. Saunders, The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor, Clin Cancer Res, vol.3, issue.12, pp.2571-80, 1997.

H. Tamaki, H. Ogawa, K. Ohyashiki, J. Ohyashiki, H. Iwama et al., The Wilms??? tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes, Leukemia, vol.13, issue.3, pp.393-402, 1999.
DOI : 10.1038/sj.leu.2401341

J. Trka, M. Kalinova, O. Hrusak, J. Zuna, O. Krejci et al., Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry, Leukemia, vol.16, issue.7, pp.161381-161390, 2002.
DOI : 10.1038/sj.leu.2402512

U. Rodeck, A. Bossler, C. Kari, C. Humphreys, T. Gyorfi et al., Expression of theWT1 Wilms' tumor gene by normal and malignant human melanocytes, International Journal of Cancer, vol.83, issue.1, pp.78-82, 1994.
DOI : 10.1002/ijc.2910590116

A. Viel, F. Giannini, E. Capozzi, V. Canzonieri, C. Scarabelli et al., Molecular mechanisms possibly affecting WT1 function in human ovarian tumors, International Journal of Cancer, vol.90, issue.4, pp.515-536, 1994.
DOI : 10.1002/ijc.2910570413

L. Bergmann, C. Miething, U. Maurer, J. Brieger, T. Karakas et al., High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse longterm outcome, pp.901217-901242, 1997.

M. Hirose, The role of Wilms' tumor genes, J Med Invest, vol.46, pp.3-4130, 1999.

A. Zaia, G. Fraizer, L. Piantanelli, and G. Saunders, Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1, Anticancer Res, vol.21, issue.1A, pp.1-10